388
Views
43
CrossRef citations to date
0
Altmetric
Functional Disorders

Societal costs for irritable bowel syndrome – a population based study

, &
Pages 582-591 | Received 16 Oct 2009, Accepted 19 Jan 2010, Published online: 18 Feb 2010

References

  • Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 2002;24:675–89.
  • Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003;17:643–50.
  • Saito YA, Schoenfeld P, Locke GR 3rd. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002;97:1910–5.
  • El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002;16:1171–85.
  • Quigley EMM, Bergmann J, Bytzer P, Fried M, Hunt R, Hungin AP, Systematic review on the management of irritable bowel syndrome in the European Union. Eur J Gastroenterol Hepatol 2007;19(Suppl 1):S1–37.
  • Akehurst RL, Brazier JE, Mathers N, O'Keefe C, Kaltenthaler E, Morgan A, Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics 2002;20:455–62.
  • Levy RL, Von Korff M, Whitehead WE, Stang P, Saunders K, Jhingran P, Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol 2001;96:3122–9.
  • Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995;109:1736–41.
  • Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569–80.
  • Mearin F, Badia X, Balboa A, Baro E, Caldwell E, Cucala M, Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001;36:1155–61.
  • Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 2000;95:3176–83.
  • Hillilä MT, Farkkilä MA. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Aliment Pharmacol Ther 2004;20:339–45.
  • Mearin F, Roset M, Badia X, Balboa A, Baro E, Ponce J, Splitting irritable bowel syndrome: From original Rome to Rome II criteria. Am J Gastroenterol 2004;99:122–30.
  • Badia X, Mearin F, Balboa A, Baro E, Caldwell E, Cucala M, Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics 2002;20:749–58.
  • Ricci J, Guerreiro T, Jones T, Schultes H, Volz A, Kessabi S. Irritable bowel syndrome: a comparison of the economic (direct and indirect) burden in four European countries. Gut 2002;51(Suppl III):A107.
  • Le Pen C, Ruszniewski P, Gaudin AF, Amouretti M, Bommelaer G, Frexinos J, The burden cost of French patients suffering from irritable bowel syndrome. Scand J Gastroenterol 2004;39:336–43.
  • Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 2006;24:21–37.
  • Hujanen T. Terveydenhuollon yksikkökustannukset suomessa vuonna 2001 (Unit costs in Finnish health care in 2001). Helsinki: National Research and Developement Center for Welfare and Health (Stakes); 2003.
  • Statistical Yearbook of Finland 2002. Helsinki: Statistics Finland; 2003.
  • Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL, editors. Methods for the economic evaluation of health care programmes. 3rd ed. Toronto, Canada: Oxford University Press; 2005.
  • Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 2000;19:3219–36.
  • Shih YC, Barghout VE, Sandler RS, Jhingran P, Sasane M, Cook S, Resource utilization associated with irritable bowel syndrome in the United States 1987–1997. Dig Dis Sci 2002;47:1705–15.
  • Heaton KW, O'Donnell LJ, Braddon FE, Mountford RA, Hughes AO, Cripps PJ. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology 1992;102:1962–7.
  • Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: a population based study. Gut 1997;41:394–8.
  • Williams RE, Black CL, Kim HY, Andrews EB, Mangel AW, Buda JJ, Determinants of healthcare-seeking behaviour among subjects with irritable bowel syndrome. Aliment Pharmacol Ther 2006;23:1667–75.
  • Fullerton S. Functional digestive disorders (FDD) in the year 2000 – economic impact. Eur J Surg 1998;164(Suppl 12):62–4.
  • Social protection and health care expenditure 2002. Official Statistics of Finland. National Research and Development Centre for Welfare and Health STAKES; 2004.
  • Muller-Lissner SA, Bollani S, Brummer RJ, Coremans G, Dapoigny M, Marshall JK, Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion 2001;64:200–4.
  • Inadomi JM, Fennerty MB, Bjorkman D. Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther 2003;18:671–82.
  • Healthcare admission registry. Helsinki: National Research and Development Centre for Welfare and Health; 2002.
  • Bentkover JD, Field C, Greene EM, Plourde V, Casciano JP. The economic burden of irritable bowel syndrome in Canada. Can J Gastroenterol 1999;Suppl A:89A–96A.
  • Muller-Lissner SA, Pirk O. Irritable bowel syndrome in Germany. A cost of illness study. Eur J Gastroenterol Hepatol 2002;14:1325–9.
  • Heikkinen MT, Pikkarainen PH, Takala JK, Räsänen HT, Eskelinen MJ, Julkunen RJ. Diagnostic methods in dyspepsia: the usefulness of upper abdominal ultrasound and gastroscopy. Scand J Prim Health Care 1997;15:82–6.
  • Francis CY, Duffy JN, Whorwell PJ, Martin DF. Does routine abdominal ultrasound enhance diagnostic accuracy in irritable bowel syndrome? Am J Gastroenterol 1996;91:1348–50.
  • American College of Gastroenterology Task Force on Irritable Bowel Syndrome. An evidence-based systematic review on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104:S1–35.
  • Thompson WG, Creed F, Drossman DA, Heaton KW, Mazzacca G. Functional bowel disease and functional abdominal pain. Gastroenterol Int 1992;6:75–91.
  • El-Serag HB, Pilgrim P, Schoenfeld P. Systemic review: natural history of irritable bowel syndrome. Aliment Pharmacol Ther 2004;19(8):861–70.
  • Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002;122:1140–56.
  • Saukkonen S, Rintanen H. Terveyskeskuskäynnit vuosina 1985–2004 [Outpatient visits at health centres 1985–2004]. Helsinki: National Research and Development Centre for Welfare and Health; 2005.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.